Pathway Financial Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.45M | Sell |
39,577
-552
| -1% | -$48.1K | 1.12% | 29 |
|
2025
Q1 | $3.61M | Buy |
40,129
+324
| +0.8% | +$29.1K | 1.24% | 27 |
|
2024
Q4 | $3.18M | Sell |
39,805
-832
| -2% | -$66.5K | 1.07% | 30 |
|
2024
Q3 | $3.66M | Buy |
40,637
+1,216
| +3% | +$109K | 1.66% | 19 |
|
2024
Q2 | $3.09M | Buy |
39,421
+868
| +2% | +$68.1K | 1.11% | 27 |
|
2024
Q1 | $3.36M | Buy |
38,553
+2,557
| +7% | +$223K | 1.21% | 24 |
|
2023
Q4 | $2.97M | Sell |
35,996
-163
| -0.5% | -$13.4K | 1.13% | 27 |
|
2023
Q3 | $2.83M | Buy |
+36,159
| New | +$2.83M | 1.17% | 28 |
|
2023
Q1 | $2.66M | Buy |
32,999
+7,882
| +31% | +$635K | 1.07% | 29 |
|
2022
Q4 | $1.95M | Buy |
+25,117
| New | +$1.95M | 0.79% | 44 |
|